Tag Archives: fund

Fund 101 Launched

Fund 101 Launched

Website Here

If you have an idea for a business and need a bit of cash to get started or you’re running a small business and need up to £500 to buy equipment, promotion flyers, hardware etc, you can apply.

Apply for between £50 and £5000 and once you receive the money, the only thing we ask is you agree to be profiled on the site so we can see how you’re getting on. The money doesn’t have to be paid back; it’s for you to use on your idea or business.

Apply via clicking the button below and outline how much money you need and for what purpose. Make a good case for your idea and then encourage as many people as possible to vote for you. The number of votes required is equal to the amount of funding you’re looking for so to obtain £500 you’ll need to secure 500 virtual votes.

Remember, the Enterprise Nation community will help you spend the dosh! Want to use it to buy a camera to take good pictures of your products? Ask peers about the best deal on the market. Want to spend the money on a Google Adwords campaign but not sure where to start? Watch our video clips that will show you how!

All the support you need is right here so you can access the money you need and keep coming back to pick up tips, access content and pose questions in our friendly forums.


For Assistance with Business Plannign and Fundraising Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

Fill Out the Short Form Below…


  1. (required)


  2. (valid email required)

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

BUPA Foundation Strategy – Fund

BUPA Foundation Strategy – Fund

Full Text Here

The Bupa Foundation is an independent medical research charity

AIMS

The charitable objects (intentions) expressed above are interpreted in the aims to fund:

  1. Implementation of translational and action orientated research-based solutions, which: :
    • Drive tangible action to prevent or alleviate chronic disease or the adverse elements of ageing; and to promote wellbeing and/or
    • Lead to the sustained uptake of healthy lifestyles and/or
    • Measurably improve public health to a significant degree
  2. AND/OR

  3. Research which leads to the development of such solutions.

OBJECTIVES

The Foundation’s objectives are:
To offer grants to implement research-based solutions, in any of the following areas, which reflect global challenges in public health:

  1. Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace or educational establishments;
  2. Utilising or developing shared-decision making tools for better patient decisions for use amongst disadvantaged or diverse groups;
  3. Promoting and encouraging healthy ageing through physical activity and other behaviour-based and social solutions for the older age group (65+ years);
  4. Using new technologies to organise and interpret health outcomes data cheaply and effectively – for better design of community health activities and to improve patient decision making.

All projects should develop, apply or test research-based approaches in community settings – with clear intended impacts on public health.

The Bupa Foundation supports high quality medical research through its four programmes:

Programme 1: Research grants (all four objectives above)

In 2011 the first round under the new funding strategy will be held in June 2011. The closing date for this round is 31 March 2011. This may change in future years.

All projects funded under this heading should develop, apply or test research-based approaches in community settings – with clear intended impacts on public health.

The areas for funding as detailed above are not intended to be exclusive of each other.

Research grant applications are open only to clinicians, researchers and health care professionals who are UK residents. Applicants are encouraged to include on their application partnerships with other universities, healthcare organisations, research institutes, charities and community groups

The Foundation will normally consider applications for funding to a maximum of £100,000 per annum for up to three years term. Successful applications are more likely if added value (such as potential for co-funding) is clearly demonstrated.

If funding is required for a longer period a separate application must be made in the third year. Continuing support cannot be guaranteed; any application for further funding will be considered in open competition with other applications submitted on that occasion.

Programme 2: Annual Multi-country Grant

A total grant of up to £600,000 will be awarded to fund one multi-country* initiative of 1 to 3 years duration, under the first funding theme on sustained behaviour changes

“Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace or educational establishments”"

*This should be defined as a project carried out in at least two of the following countries: United Kingdom, Spain, Australia, New Zealand, the United States or India

It will be advertised on the Bupa Foundation web site and appropriate online journals.

In 2011 it will be judged in September, with a closing date of 20 June 2011.

This time table may change in future years.

Programme 3: Philip Poole-Wilson Seed Corn Fund

A fund of £200,000 per annum to award grants of up to £20,000 each, to fund research into any of the four Research Grant themes.

Each application must be made either by a researcher beginning their research career or if a pilot project by an experienced researcher, must include such a researcher on the team and contribute meaningfully to his/her development and training. High priority will be given to applications from young and/or new researchers who have not previously been funded.

Philip Poole-Wilson Seed Corn fund grant applications are open only to clinicians, researchers and health care professionals who are UK residents Applicants are encouraged to include on their application partnerships with other universities, healthcare organisations, research institutes, charities and community groups

This grant round will be held in November each year, with a closing date of 31 July.

Programme 4: Annual Prizes

£60,000 will be allocated for completed research and/or development that has been conducted over the past 3 years into each of the four Research themes; -

  1. Healthy Lives Prize
  2. Enabling sustained behaviour changes in physical activity and/or nutrition amongst children, families or in the workplace

  3. Patients as Partners Prize
  4. Utilising or developing shared-decision making tools for better patient decisions for use amongst disadvantaged or diverse groups;

  5. Vitality for Life Prize
  6. Promoting and encouraging healthy ageing through physical activity and other behaviour-based and social solutions for the older age groups (65+ years)

  7. Technology for Healthy Outcomes Prize
  8. Using new technologies to organise and interpret health outcomes data cheaply and effectively for better design of community health activities and improved patient decision making.

Foundation Prizes will focus on recognition of excellent work by aspiring and promising new researchers in the early phases of their career.

Foundation Prizes are advertised in January/February each year, with a closing date in early July. Full details of Awards entry criteria and the application process can be found at: http://www.bupafoundation.co.uk/asp/awards/eligibility.asp.

The Chairman and Board of Governors of the Bupa Foundation reserve the right to amend and/or add to Programme details as they consider appropriate, at any future date.

For Assistance with Grant Funding and Business Planning Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

Fill Out the Short Form Below…


  1. (required)


  2. (valid email required)

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

Michael J. Fox Foundation Commits up to US$12 Million for Targeted Parkinson’s Therapeutic Development in 2011

Michael J. Fox Foundation Commits up to US$12 Million for Targeted Parkinson’s Therapeutic Development in 2011

Full Text Here

Funding is open to academic and industry researchers through the Foundation’s Pipeline Programs, which consist of three annually recurring initiatives, known collectively as The Edmond J. Safra Core Programs for PD Research, as well as the industry-exclusive Therapeutics Development Initiative. The Foundation seeks investigator-initiated proposals focused on the following critical points along the translational pathway to new therapies for Parkinson’s disease:

  • Testing Novel Hypotheses: Quick support for high-risk, high-reward projects with little to no existing preliminary data, but potential to significantly impact our understanding or treatment of PD.
  • Validating Novel Targets: Support for work demonstrating whether modulation of a novel biological target has impact in a PD-relevant pre-clinical model — an essential step to the development of potential targeted therapies.
  • Catalyzing and Expanding Preclinical Development: Industry-exclusive support for preclinical development of Parkinson’s disease therapies with potential to fundamentally alter disease course and/or improve treatment of symptoms above and beyond current standards of care.
  • Clinically Testing Novel Therapies: Support for clinical testing of promising PD therapies that may significantly and fundamentally improve treatment of PD.

“The Pipeline Programs are a core element of our Foundation’s efforts to drive research that will speed therapeutic development at historically under-funded points on the pipeline,” said Todd Sherer, the Foundation’s acting CEO. “The programs are part of MJFF’s progressive work to keep the most promising and significant projects moving forward toward notably improving quality of life for patients now and in the future.”

Brief program descriptions follow. Full details are available at www.michaeljfox.org/research.

For Business Planning Services Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

First name

Phone #1

E-mail address

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

New Oxford Fund to Bridge Innovation Gap

New Oxford Fund to Bridge Innovation Gap

A new Fund launched today by Oxford University will enable donors to support proof of concept and prototyping work to turn more research ideas into commercially-viable technologies, products and services.

The Oxford Invention Fund, which will be managed by Oxford University’s technology transfer company Isis Innovation, is part of Oxford Thinking, the Campaign to raise a minimum of £1.25bn for the collegiate University.

It is widely recognised that there is an ‘innovation gap’ between the early stages of an invention or idea and the point when it is mature enough to be commercialised through a license or spin-out company. The new initiative aims to raise up to £5m to create a self-sustaining fund to help develop Oxford inventions to the point when they can attract commercial investment.

‘Many university-based inventions lack well-developed product prototypes and vital experimental data to help them succeed, and obtaining funds for such work from venture capital providers or research funders is still a problem,’ said Tom Hockaday, Managing Director of Isis Innovation. ‘The aim of this Fund is to support the work needed to make even more Oxford inventions attractive propositions for licensing or investment.’

‘The Oxford Invention Fund provides the opportunity for donors to the University to see their donations used to support innovation and enterprise in Oxford, and to see a return to the University from successful new business ventures,’ said Bernard Taylor, Chairman of Isis Innovation.

Isis Innovation has a long track-record of success in exploiting research discoveries and ideas from Oxford University. In the last ten years Isis has set up 54 new technology spin-out companies, over 90% of which are still in business, and concluded 500 technology licensing transactions. Isis currently manages over 750 technology projects and files on average more than one new patent application each week.

Isis Innovation has managed the highly successful Oxford University Challenge Seed Fund (UCSF) which, since it was first launched in 1999, has awarded £5.7m, financing 102 projects and prompting the formation of 31 spin-out companies and the completion of 51 commercial deals.

The Oxford Invention Fund is modelled after the UCSF, with returns from its investments re-invested in further projects so that it can continue to support innovation at Oxford for many years to come. It is hoped that one day money generated from the Fund could be used to subsidise scholarships and bursaries to help the next generation of inventors and scientists.

For Business Planning and Fund Raising Services Click Here

Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!

Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.

First name

Phone #1

E-mail address

ida consultants freestrategyconsultation 515x64 New Oxford Fund to Bridge Innovation Gap

Free Strategy Consultation - Biotech Pharma Regualtory

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

ida 100programme 515x64 LowRes New Oxford Fund to Bridge Innovation Gap

£70 million Boost for UK manufacturing (including Regenerative medicines)

£70 million Boost for UK manufacturing (including Regenerative medicines)

Full Text Here

The first three state of the art manufacturing research centres funded under a new £70M Government investment will be based at Southampton, Loughborough and Brunel universities, to help UK businesses develop the technology products of the future and underpin manufacturing growth, Business Secretary Lord Mandelson announced today.

The three new Engineering and Physical Sciences Research Council (EPSRC) centres will focus research efforts in the fields of:

  • Photonics (the science and application of light using optical fibres to revolutionise the internet and telecommunications) at Southampton;
  • Regenerative Medicine (therapies to enable damaged, diseased or defective tissues to work normally again) at Loughborough; and
  • Liquid Metals (developing innovative technologies for the reuse and recycling of metal) at Brunel

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free.

As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

First name

E-mail address

This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
ida consultants freestrategyconsultation 515x64 £70 million Boost for UK manufacturing (including Regenerative medicines)

ida 100programme 515x64 LowRes £70 million Boost for UK manufacturing (including Regenerative medicines)

Turn your Business Into an Investor Magnet

How to Write a Business Plan – Free E-Course

Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free

“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”

New Manchester University Spin Out Fund

The University of Manchester has announced a new investment fund for commercialisation, the fund is called the Premier Opportunity Fund and is dedicated to the commercialisation of the University Spin Outs. The Fund is established to make between 15 and 20 investments of between £250,000 and £750,000, it will then make follow on investment of up to £3,000,000 should it be appropriate.  The Money and business support has come from MTI a technology Management Company.

If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug  development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

ida consultants freestrategyconsultation 515x64 New Manchester University Spin Out Fund

As you know this website is a great resourse for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.

Over £220 million to boost innovation in the NHS

I went to an event last night and heard of this recently announced fund, but it had been lost in the press due to the Swine Feaver Crisis. However its interesting reading, my understanding is that this fund will be distributed to regional management and used to drive innovation and technology ddevelopment within the NHS.

A £220 million fund will be made available to encourage innovation within the NHS, Health Minister Lord Darzi announced today, during an event at the Science Museum in London to mark the launch of ‘Innovation for a Healthier Future’, a series of initiatives to nurture and reward innovation within the NHS.

Building on the Government’s firm commitment to create an innovative health service, England’s ten Strategic Health Authorities (SHAs) will each receive £2 million this year, and £5 million in each of the following four years to support frontline NHS staff in developing innovative ideas. The cash will be invested directly into a combination of projects on the ground and at regional level, speeding up the time it takes for innovative solutions to get from design bench to NHS bedside. This will benefit patients directly and increase the quality of the care they receive.

Many innovative ideas in the NHS risk not being developed due to a lack of funding. The fund has been made available to help bring these ideas about and empower the inspiration of the 1.3 million NHS staff and their colleagues in social care who make a difference each day to people’s lives.

Lord Darzi said:

‘This announcement is a huge step forward in implementing the recommendations set out last summer in my strategy on the future of the NHS.

‘NHS staff have told me that accessing the funds to make ideas become reality can be a struggle and as a result, many great ideas never get realised. That is why I am delighted to announce that we now have a £220 million innovation fund available to get those ideas off the bench and to patient bedsides, day centres or GP surgeries.

‘We know that around 40 percent of the world’s inventions over the past 50 years originated in the UK and that the NHS is rightly recognised as a world leader in the development of innovative treatments and technologies – but we can be better at putting those good ideas into action and these funds will help do exactly that.’

The Government has also announced that alongside this funding, it has put in a place a support structure on innovation for Strategic Health Authorities, with NESTA (the National Endowment for Science Technology and the Arts) and the Young Foundation acting as advisers to SHAs in bringing about a true innovation culture. The two bodies have a proven track record in nurturing and supporting innovation and assisting organisations to turn great ideas into great improvements.

Speaking about their support to the NHS, Jonathan Kestenbaum NESTA Chief Executive said:

‘The pressures on delivering high quality healthcare have never been greater. Yesterday’s solutions to tomorrow’s problems won’t work. The SHA Innovation Fund will ensure that fresh ideas and radical thinking by frontline staff can be delivered across the NHS. NESTA has developed expertise in how to encourage innovative public services and we are pleased to be able to put this into action at the very heart of public service delivery’.

In addition, Lord Darzi announced further details of the ‘Innovation Challenge Prizes’ which will engage with innovators globally and invite them to devise exciting new ways to address key health challenges.

The prizes will be a key way in which to recognise and promote emerging best practice and the Challenges themselves will be designed to engage a wide range of NHS staff.

A panel of experts will create a shortlist of possible challenges with the exact challenges announced later this year following a public engagement process. The Panel will be assisted in its work by Trevor Baylis, inventor of the wind up radio and one of this countries top inventors.

Says Trevor Baylis, ‘Britain has an outstanding heritage in innovation, from the steam engine to the MRI scanner – we are a nation of innovators who are constantly looking for new, different and better ways of doing things. The Innovation Challenges Prizes are a fantastic opportunity to create and develop ideas that can genuinely change lives for the better.’

Alongside this new investment and support, England’s Strategic Health Authorities will also be subject to a legal duty to promote innovation and support the diffusion of innovative technologies and solutions throughout the health service.

From DoH website

If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com

Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug  evelopment target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.

ida consultants freestrategyconsultation 515x64 Over £220 million to boost innovation in the NHS